Chemotherapy-induced myeloid suppressor cells and antitumor immunity: The Janus face of chemotherapy in immunomodulation
Authors:
- 3 August 2014
- journal article
- Published by Taylor & Francis in OncoImmunology
- Vol. 3 (8) , e954471
Abstract
Tumor recurrence remains a major problem for patients with cancer, even after initial beneficial responses to standard-of-care chemotherapeutic agents. With the recent advances in immunotherapy strategies, there is growing interest in synergistically combining immunotherapy with conventional chemotherapy to achieve durable antitumor effects. In some cases, chemotherapy-induced myeloid suppressor cells represent a critical obstacle to achieving this goal.Keywords
This publication has 11 references indexed in Scilit:
- Immunosuppressive Myeloid Cells Induced by Chemotherapy Attenuate Antitumor CD4+ T-Cell Responses through the PD-1–PD-L1 AxisCancer Research, 2014
- Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanismviarecruitment of myeloid-derived suppressor cellsInternational Journal of Cancer, 2013
- Blockade of Myeloid-Derived Suppressor Cells after Induction of Lymphopenia Improves Adoptive T Cell Therapy in a Murine Model of MelanomaThe Journal of Immunology, 2012
- Polyfunctional CD4+ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapyBlood, 2012
- Cyclophosphamide-induced Myeloid-derived Suppressor Cell Population Is Immunosuppressive But Not Identical to Myeloid-derived Suppressor Cells Induced By Growing TC-1 TumorsJournal of Immunotherapy, 2012
- Immunomodulatory effects of cyclophosphamide and implementations for vaccine designSeminars in Immunopathology, 2011
- Unraveling Cancer Chemoimmunotherapy Mechanisms by Gene and Protein Expression Profiling of Responses to CyclophosphamideCancer Research, 2011
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapyCancer Immunology, Immunotherapy, 2008
- Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice.2000
- Characterization of cyclophosphamide-induced suppressor cellsImmunopharmacology, 1982